跳至主要内容
临床试验/JPRN-jRCT1071230073
JPRN-jRCT1071230073招募中Unknown

The influence of remimazolam on the reversal of rocuronium-induced neuromuscular blockade with sugammadex

Fujimoto Masafumi0 个研究点目标入组 30 人开始时间: 2023年10月12日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • Patients over 18 years old scheduled for elective surgery under general anesthesia. All patients were American Society of Anesthesiologists physical status class I or II.

排除标准

  • Patients under 18 years old, emergency surgery, obesity (BMI 30 kg/m2 and more), with hepatic and renal dysfunction, with neuromuscular disorder, with contraindication to benzodiazepine

研究者

发起方
Fujimoto Masafumi

相似试验